The deal is a complex related-party acquisition that Marchex's own board acknowledges carries significant integration, customer retention, and overhang risk. The $10M note adds leverage to a company with only $9.9M cash, and full earn-out would add 4M shares (~10% dilution). The majority-of-minority vote requirement means institutional holders (Edenbrook owns 36.7% of Class B) effectively decide the outcome. Monitor proxy advisory firm recommendations and Edenbrook's public stance, as their vote will determine whether the deal closes. If approved, watch for customer retention data in quarterly filings, as the earn-out mechanics create a natural catalyst.
Price Chart
Executive Summary
Marchex is seeking stockholder approval for a related-party acquisition of Archenia, Inc., from its Chairman (Russell Horowitz) and Vice Chairman (Michael Arends) for $10M in convertible notes (6% interest, $1.80/sh conversion, 12-24 month tranches) plus up to 4M earn-out shares subject to revenue/EBITDA and retention targets. Craig-Hallum issued a fairness opinion deeming total ~$16.5M consideration fair to Marchex stockholders. The special meeting is set for July 1, 2026, requiring both a majority vote and a majority-of-minority vote (excluding Horowitz and Arends). The deal is accounted for as a common-control transfer, not a business combination, so no goodwill or fair-value step-up is recognized.
Key Financial Metrics
Key Facts
- Marchex acquires 100% of Archenia from Chairman Russell Horowitz, Vice Chairman Michael Arends, and a third seller in a related-party transaction
- Consideration: $10M in convertible promissory notes (6% interest, $1.80/sh conversion price) plus up to 4M earn-out shares of Class B common stock
- Earn-out shares tied to Archenia achieving revenue or Adjusted EBITDA exceeding 100% of baseline levels AND completing software integration or retaining 75% of pre-closing customers
- Special Committee of independent directors negotiated deal; Craig-Hallum rendered fairness opinion valuing total consideration at ~$16.52M
- Transaction accounted for as common-control transfer (not business combination); no goodwill or intangible asset step-up
- Required approvals: majority of all outstanding voting power AND majority of minority (excluding Horowitz and Arends) - special meeting on July 1, 2026
- Archenia had 2025A revenue of $17.97M, income from operations of $392K, EBITDA of $457K; negative equity of -$1.79M
- Pro forma combined 2025 revenue: ~$63.3M (Marchex $45.4M + Archenia $17.97M); pro forma combined net loss: -$5.97M
- Archenia has $2.27M in shareholder loans and $1.48M accounts payable; cash of only $358K
- Material weakness in internal controls identified during Archenia's first audit, though unqualified opinion was issued
Financial Impact
Total deal value approximately $16.5M ($10M notes + up to ~$6.5M earn-out shares at $1.63/sh), representing ~22% of Marchex's $74M market cap
Risk Factors
- Related-party conflicts: Chairman and Vice Chairman are the sellers, creating inherent governance tension despite Special Committee process
- Customer concentration risk: Archenia's top four customers represent 63% of revenue; any defection post-closing directly hits earn-out metrics
- Integration execution risk: earn-out requires both financial performance AND software integration / 75% customer retention - a high bar for a small company
- Dilution risk: up to 4M shares at $1.63/sh (~10% of outstanding Class B) if earn-out fully achieved; notes also convertible at $1.80
- Leverage risk: $10M note payable over 24 months versus Marchex's $9.9M cash balance - cash flow could tighten
- Material internal control weakness at Archenia suggests potential for post-closing accounting surprises
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| PREM14A Filing (Primary) | 0002077096-26-000175 |
| Document: ea029204801ex-fee.htm | 0002077096-26-000175 |
| Document: 0002077096-26-000175-index-headers.html | 0002077096-26-000175 |
| Document: 0002077096-26-000175-index.html | 0002077096-26-000175 |
| Document: 0002077096-26-000175.txt | 0002077096-26-000175 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Press Release | $1.42 $1.28 | ▼ −9.86% | ▼ −9.30% | $1.29 (−9.15%) |
Aug 12, 2026 10w ago | 8-K | $1.82 $1.37 | ▼ −25.00% | ▼ −23.25% | $1.29 (−29.12%) |
Jun 5, 2026 20w ago | DEFM14A | $1.53 $1.76 | ▲ +15.03% | ▲ +13.40% | $1.29 (−15.69%) |
May 26, 2026 21w ago | PREM14A | $1.63 $1.50 | ▼ −7.98% | ▼ −6.07% | $1.29 (−20.86%) |
May 13, 2026 23w ago | 8-K | $1.62 $1.55 | ▼ −4.32% | ▼ −3.46% | $1.29 (−20.37%) |
May 13, 2026 23w ago | DEFA14A | $1.62 $1.55 | ▼ −4.32% | ▼ −3.46% | $1.29 (−20.37%) |
May 1, 2026 25w ago | 8-K | $1.73 $1.67 | ▼ −3.47% | ▼ −9.11% | $1.29 (−25.43%) |
Apr 17, 2026 27w ago | 10-K/A | $1.72 $1.66 | ▼ −3.49% | ▼ −7.69% | $1.29 (−25.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers